Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared on LinkedIn:
“Encouraging signals as the immunotherapy story evolves for patients with microsatellite stable (MSS) colorectal cancer.
Vilastobart (XTX101) – Tumor-activated Fc-enhanced CTLA-4 and PD-L1 showing deep/durable responses.
‘Cures’.”
